Broad‐Spectrum Profiling of Drug Safety via Learning Complex Network

Drug safety is a severe clinical pharmacology and toxicology problem that has caused immense medical and social burdens every year. Regretfully, a reproducible method to assess drug safety systematically and quantitatively is still missing. In this study, we developed an advanced machine learning model for de novo drug safety assessment by solving the multilayer drug‐gene‐adverse drug reaction (ADR) interaction network. For the first time, the drug safety was assessed in a broad landscape of 1,156 distinct ADRs. We also designed a parameter ToxicityScore to quantify the overall drug safety. Moreover, we determined association strength for every 3,807,631 gene‐ADR interactions, which clues mechanistic exploration of ADRs. For convenience, we deployed the model as a web service ADRAlert‐gene at http://www.bio-add.org/ADRAlert/. In summary, this study offers insights into prioritizing safe drug therapy. It helps reduce the attrition rate of new drug discovery by providing a reliable ADR profile in the early preclinical stage.

[1]  Gary D. Bader,et al.  GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop , 2010, Bioinform..

[2]  Robert Ball,et al.  Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology , 2018, J. Biomed. Informatics.

[3]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[4]  Emanuel J. V. Gonçalves,et al.  A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.

[5]  Ethan Basch,et al.  Patient-reported outcomes and the evolution of adverse event reporting in oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Leora Simon,et al.  March1 E3 Ubiquitin Ligase Modulates Features of Allergic Asthma in an Ovalbumin-Induced Mouse Model of Lung Inflammation , 2018, Journal of immunology research.

[7]  L. Khan,et al.  Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay – a systematic review , 2013, European Journal of Clinical Pharmacology.

[8]  C Helma,et al.  Prediction of Adverse Drug Reactions Using Decision Tree Modeling , 2010, Clinical pharmacology and therapeutics.

[9]  Yi-Ping Phoebe Chen,et al.  Machine learning on adverse drug reactions for pharmacovigilance. , 2019, Drug discovery today.

[10]  J E Ridings,et al.  Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. , 1996, Toxicology.

[11]  Atul Kumar,et al.  The Newly Available FAERS Public Dashboard: Implications for Health Care Professionals , 2018, Hospital pharmacy.

[12]  Piotr Kuna,et al.  MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis , 2013, Archives of medical science : AMS.

[13]  G. Shepherd,et al.  Adverse Drug Reaction Deaths Reported in United States Vital Statistics, 1999-2006 , 2012, The Annals of pharmacotherapy.

[14]  Lin He,et al.  SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome , 2009, Nucleic Acids Res..

[15]  M. Milik,et al.  Mapping adverse drug reactions in chemical space. , 2009, Journal of medicinal chemistry.

[16]  Ferenc Darvas,et al.  HazardExpert: An Expert System for Predicting Chemical Toxicity , 1992 .

[17]  Peer Bork,et al.  The SIDER database of drugs and side effects , 2015, Nucleic Acids Res..

[18]  H S Rosenkranz,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE. , 1994, Mutation research.

[19]  Fleur Mougin,et al.  Mapping of the WHO-ART terminology on Snomed CT to improve grouping of related adverse drug reactions , 2006, MIE.

[20]  Bin Chen,et al.  Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets , 2017, Nature Communications.

[21]  Azeem Majeed,et al.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.

[22]  Sergio E. Wong,et al.  Adverse Drug Reaction Prediction Using Scores Produced by Large-Scale Drug-Protein Target Docking on High-Performance Computing Machines , 2014, PloS one.

[23]  J. Chen,et al.  Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures , 2013, Proteomics.

[24]  Quan Xu,et al.  ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms , 2014, Nucleic Acids Res..

[25]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[26]  Tanya Barrett,et al.  The Gene Expression Omnibus Database , 2016, Statistical Genomics.

[27]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[28]  Christopher Gerner,et al.  Quantitative proteome profiling of cells and tissues: A new tool for biomedical research , 2004 .

[29]  K Enslein,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program. , 1994, Mutation research.

[30]  D. Lewis,et al.  COMPACT: a structural approach to the modelling of cytochromes P450 and their interactions with xenobiotics , 2001 .

[31]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[32]  Zhi-Liang Ji,et al.  High-throughput identification of off-targets for the mechanistic study of severe adverse drug reactions induced by analgesics. , 2014, Toxicology and applied pharmacology.

[33]  Justin Lamb,et al.  The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.

[34]  Robert Petryszak,et al.  ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..

[35]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[36]  Arshadul Haque,et al.  Postmarketing Surveillance Studies-An Industry Perspective on Changing Global Requirements and Implications. , 2017, Clinical therapeutics.

[37]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[38]  Jianying Hu,et al.  Predicting adverse drug reactions through interpretable deep learning framework , 2018, BMC Bioinformatics.

[39]  J. Wooten,et al.  Reporting adverse drug reactions. , 2009, Southern medical journal.

[40]  Farrah Kheradmand,et al.  Differential requirement for CD18 in T-helper effector homing , 2003, Nature Medicine.

[41]  Gary D. Bader,et al.  GeneMANIA Prediction Server 2013 Update , 2013, Nucleic Acids Res..

[42]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[43]  Ben Y. Reis,et al.  Predicting Adverse Drug Events Using Pharmacological Network Models , 2011, Science Translational Medicine.

[44]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[45]  K. Enslein,et al.  Use of SAR in computer-assited prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program , 1994 .

[46]  E. Brown,et al.  The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.

[47]  R. Harrison,et al.  Phase II and phase III failures: 2013–2015 , 2016, Nature Reviews Drug Discovery.

[48]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2017 , 2016, Nucleic Acids Res..

[49]  Vladimir V Poroikov,et al.  In silico assessment of adverse drug reactions and associated mechanisms. , 2016, Drug discovery today.

[50]  Darrell R Abernethy,et al.  Systems pharmacology to predict drug toxicity: integration across levels of biological organization. , 2013, Annual review of pharmacology and toxicology.

[51]  Hua Xu,et al.  Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs , 2012, J. Am. Medical Informatics Assoc..

[52]  Cheng Cheng,et al.  Rapid Assessment of Adverse Drug Reactions by Statistical Solution of Gene Association Network , 2015, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[53]  Yumi Kameyama,et al.  Factors Associated with Prolonged Hospital Stay in a Geriatric Ward of a University Hospital in Japan , 2012, Journal of the American Geriatrics Society.

[54]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[55]  Andrew D. Rouillard,et al.  LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures , 2014, Nucleic Acids Res..